Skip to main content
Journal cover image

The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention.

Publication ,  Journal Article
Kessler, DA; Grima, KM; Valinsky, JE; Ortiz, C; Hillyer, CD; Nandi, V; Jones, RL; Shaz, BH
Published in: Transfus Apher Sci
October 2013

BACKGROUND AND OBJECTIVES: Some blood centers provide health screening as a public health measure and to encourage donation. The goal of the current study was to provide cardiovascular disease (CVD) screening to donors using high-throughput testing and web-based communications. MATERIALS AND METHODS: CVD risk screening was offered to donors at selected mobile drives in a large metropolitan area. Risk factors were determined by donor questionnaire, laboratory testing (total cholesterol, HDL levels and hemoglobin A1c), and blood pressure measurement. Results were reported to participants via mail and website. A 60-day follow up web-based survey was sent to participants via email to assess the impact of the program on donor's behavior. RESULTS: 9435 donors, 17-75 years old participated with the following risk factors: 61.3% BMIs>25, 28.8% high total cholesterol, and 31.4% lower than recommended HDL levels. 25.3% of donors that responded to the follow up survey went to see their health care provider based on screening results and 9% of these received new or modified treatment. CONCLUSION: In our sample, blood donors are healthier than the general population, but many still have CVD risk factors, particularly obesity. CVD screening can be successfully used to make donors aware of this important health information and some donors act on this information.

Duke Scholars

Published In

Transfus Apher Sci

DOI

ISSN

1473-0502

Publication Date

October 2013

Volume

49

Issue

2

Start / End Page

263 / 267

Location

England

Related Subject Headings

  • Surveys and Questionnaires
  • Risk Assessment
  • Middle Aged
  • Male
  • Humans
  • Glycated Hemoglobin
  • Follow-Up Studies
  • Female
  • Donor Selection
  • Cholesterol
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kessler, D. A., Grima, K. M., Valinsky, J. E., Ortiz, C., Hillyer, C. D., Nandi, V., … Shaz, B. H. (2013). The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. Transfus Apher Sci, 49(2), 263–267. https://doi.org/10.1016/j.transci.2013.06.018
Kessler, Debra A., Kathleen M. Grima, Jay E. Valinsky, Caroline Ortiz, Christopher D. Hillyer, Vijay Nandi, Robert L. Jones, and Beth H. Shaz. “The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention.Transfus Apher Sci 49, no. 2 (October 2013): 263–67. https://doi.org/10.1016/j.transci.2013.06.018.
Kessler DA, Grima KM, Valinsky JE, Ortiz C, Hillyer CD, Nandi V, et al. The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. Transfus Apher Sci. 2013 Oct;49(2):263–7.
Kessler, Debra A., et al. “The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention.Transfus Apher Sci, vol. 49, no. 2, Oct. 2013, pp. 263–67. Pubmed, doi:10.1016/j.transci.2013.06.018.
Kessler DA, Grima KM, Valinsky JE, Ortiz C, Hillyer CD, Nandi V, Jones RL, Shaz BH. The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. Transfus Apher Sci. 2013 Oct;49(2):263–267.
Journal cover image

Published In

Transfus Apher Sci

DOI

ISSN

1473-0502

Publication Date

October 2013

Volume

49

Issue

2

Start / End Page

263 / 267

Location

England

Related Subject Headings

  • Surveys and Questionnaires
  • Risk Assessment
  • Middle Aged
  • Male
  • Humans
  • Glycated Hemoglobin
  • Follow-Up Studies
  • Female
  • Donor Selection
  • Cholesterol